T

Terns Pharmaceuticals
D

TERN

34.470
USD
0.36
(1.06%)
مغلق
حجم التداول
71,425
الربح لكل سهم
-1
العائد الربحي
-
P/E
-34
حجم السوق
3,749,208,176
أصول ذات صلة المقالات

العنوان: Terns Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.